The role of Diaskintest in detecting tuberculosis in adult patients: A clinical case

The complexity of the differential diagnosis of tuberculosis is due to a combination of factors that lead to diagnostic difficulties and errors. At the forefront of this variability are: the similarity of the clinical and radiological picture of lung diseases with the absence of pathognomonic signs; the pathomorphosis and variability of clinical manifestations of lung diseases, where there is often a diversity of clinical variants of the same nosology. Some diseases with no established etiology (such as sarcoidosis and obliterative bronchiolitis) often mimic tuberculosis. At the current stage, the arsenal of tools that allows for the timely detection and diagnosis of the etiology of pathological changes in the lungs includes a recombinant tuberculosis allergen test (ATR) — the Diaskintest® preparation. Immunodiagnostics plays a leading role in establishing the presumed diagnosis of tuberculosis. This method allows for effective screening not only for active tuberculosis but also for latent tuberculosis infection in individuals with non-tuberculous lesions of the chest organs. Thus, Diaskintest® successfully addresses the issues of detection and differential diagnosis in real clinical practice within diagnostic algorithms for excluding tuberculosis. The article presents a clinical observation of newly diagnosed pulmonary tuberculosis in a 30-year-old man. A distinctive feature of this case is that, in the absence of detection of the tuberculosis pathogen in the early stages of the disease, it was the positive result of the Diaskintest that guided the diagnostic search. As further examination results showed, the probable diagnosis established based on the positive ATR test completely matched the verified diagnosis of tuberculosis. The use of the ATR test allowed for a reduction in the diagnostic pause interval and the timely initiation of appropriate therapy for the patient, even with a negative microscopy result during the differential diagnosis stage.

1. Kudlay DA, Doktorova NP. ESAT-6 and CFP-10 antigens as a biotechnology molecule substrate. Applications in medicine. Russian Journal of Infection and Immunity. 2022;12(3):439-449. (In Russ.) httpy/doi.org/10.15789/2220-7619-EAC-1763.

2. Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol. 1996;178(5):1274-1282. https//doi.org/10.1128/jb.178.5.1274-1282.1996.

3. Kudlay DA. Hybrid proteins CFP10 and ESAT6. A path from developing a molecule to population screening for TB infection. Immunologiya. 2021;42(2): 166-174. (In Russ.) https//doi.org/10.33029/0206-4952-2021-42-2-166-174.

4. Bogorodskaya EM, Slogotskaya LV, Shamuratova LF, Sevostyanova TA. Screening for tuberculosis infection in children and adolescents by two intracutaneous tests: with tuberculin and tuberculosis recombinant allergen (ESAT-6/CFP-10) in Moscow in 2021. Tuberculosis and Lung Diseases. 2022;100(11):29-38. (In Russ.) https://doi.org/10.21292/2075-1230-2022-100-11-29-38.

5. Shovkun L, Aksenova V, Kudlay D, Sarychev A. The role of immunological tests in the diagnosis of tuberculosis infection in children with juvenile idiopathic arthritis (JIA). European Respiratory Journal. 2018;52(Suppl. 62): PA2733. https://doi.org/10.1183/13993003.congress-2018.PA2733.

6. Zellweger JP, Sotgiu G, Corradi M, Durando P. The diagnosis of latent tuberculosis infection (LTBI): currently available tests, future developments, and perspectives to eliminate tuberculosis (TB). Med Lav. 2020;111(3):170-183. https://doi.org/10.23749/mdl.v111i3.9983.

7. Stogova NA. Possible Use of Tuberculous Recombinant Allergen Test in the Differential Diagnosis of Diseases in the Upper Lung Lobes in Adults. Tuberculosis and Lung Diseases. 2022;100(3):23-27. (In Russ.) https://doi.org/10.21292/2075-1230-2022-100-3-23-27.

8. Shmelev EI, Zaitseva AS, Makaryants NN, Kovalevskaya MN, Sargsyan AP. Patients with non-tuberculous mycobacteriosis in clinical practice. Pulmonologiya. 2022;32(1):95-102. (In Russ.). 2022;32(1):95-102. https://doi.org/10.18093/0869-0189-2022-32-1-95-102.

9. Vasilyeva IA, Aksenova VA, Kazakov AV, Kiseleva YY, Maryandyshev AO, Dolzhenko EN et al. Evaluation of the specificity of an intradermal test with recombinant tuberculosis allergen in bacillus Calmette-Guerin- vaccinated healthy volunteers. Front Med. 2023;10:1042461. https://doi.org/10.3389/fmed.2023.1042461.

10. Morozova TI, Doktorova NP. Latent tuberculosis infection in risk groups of the adult population of the Saratov Region. Meditsinskiy Sovet. 2023;17(4):82-90. (In Russ.) https://doi.org/10.21518/ms2023-054.

11. Stogova NA. Immunological skin tests in differential diagnostics disseminated processes in the lungs. Pulmonologiya. 2020;30(4):446-452. (In Russ.) https://doi.org/10.18093/0869-0189-2020-30-4-446-452.

12. Stogova NA, Pecherskikh AI, Rusnak AS. Skin test diaskintest for the diagnosis of tuberculous exudative pleuritis. Tuberculosis and Lung Diseases. 2014;(4):54-58. (In Russ.) Available at: https://www.elibrary.ru/sbdujd.

13. Dubrovskaya II, Bagisheva NV, Mordyk AV, Nebesnaya EY, Bakhshieva LI. Detection and differential diagnosis of tuberculosis in patients of the pulmonary department with community-acquired pneumonia and chronic obstructive pulmonary disease. Pulmonologiya. 2020;30(3):305-311. (In Russ.) https://doi.org/10.18093/0869-0189-2020-30-3-305-311.

14. Yagudina RI, Zinchuk IYu. Pharmacoeconomic study of skin tests in the diagnostics of tuberculosis infection. Farmakoekonomika. Modern Pharmacoeconomics and Pharmacoepidemiology. 2013;6(1):11-15. (In Russ.) Available at: https://www.pharmacoeconomics.ru/jour/article/view/17.